Valuation: TransMedics Group, Inc.

Market Cap 3.26B 2.79B 2.61B 2.39B 4.49B 312B 4.58B 30.88B 12.03B 156B 12.23B 11.97B 518B P/E 2026 *
67.1x
P/E 2027 * 42.2x
Enterprise Value 3.22B 2.75B 2.57B 2.36B 4.44B 308B 4.52B 30.5B 11.88B 154B 12.08B 11.82B 512B EV / Sales 2026 *
4.34x
EV / Sales 2027 * 3.56x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-3.32%
1 week+4.40%
Current month+18.74%
1 month+22.80%
3 months+37.38%
6 months-31.63%
Current year-25.32%
1 week 86.8
Extreme 86.8
94.99
1 month 68
Extreme 68
94.99
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 55 2024-12-01
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
Date Insider Type Main position Quantity % Market Cap.
8/17/26 Don

Chairman

-18,000 0.0528%
7/10/26 Free

Chief Financial Officer

43,399 0.1273%
7/10/26 Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
-3.32%+4.40%-25.95%+38.87% 3.26B
+2.28%+4.07%+25.94%+17.88% 227B
+2.09%+4.92%+1.75%-14.12% 149B
-5.84%-6.68%-21.85%+30.96% 141B
-5.08%-3.99%-52.41%-1.63% 75.37B
-2.65%-3.46%+13.81%+17.30% 53.19B
-0.43%+2.00%-16.51%-12.52% 51.88B
+0.57%+5.44%+30.13%+31.07% 43.89B
-2.68%-2.75%+35.93%+49.89% 40.86B
-0.75%+2.46%+0.12%+8.34% 33.7B
Average -0.96%+2.04%-0.90%+16.60% 81.82B
Weighted average by Cap. +0.27%+1.33%+2.09%+12.54%

Financials

2026 *2027 *
Net sales 742M 635M 593M 544M 1.02B 70.98B 1.04B 7.03B 2.74B 35.55B 2.78B 2.72B 118B 875M 749M 700M 642M 1.21B 83.71B 1.23B 8.29B 3.23B 41.92B 3.28B 3.21B 139B
Net income 52.34M 44.8M 41.87M 38.39M 72.15M 5.01B 73.57M 496M 193M 2.51B 197M 192M 8.32B 90.29M 77.29M 72.23M 66.22M 124M 8.64B 127M 856M 333M 4.33B 339M 332M 14.35B
Net Debt -40.26M -34.46M -32.2M -29.52M -55.49M -3.85B -56.58M -382M -149M -1.93B -151M -148M -6.4B -146M -125M -117M -107M -201M -13.94B -205M -1.38B -538M -6.98B -547M -535M -23.15B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26-08-20 US$90.85 -3.32% 588,226
26-08-19 US$93.97 +3.62% 703,325
26-08-18 US$90.69 +2.65% 778,302
26-08-17 US$88.35 -0.26% 514,254
26-08-14 US$88.58 -1.18% 434,039
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
90.85USD
Average target price
97.30USD
Spread / Average Target
+7.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock